Stonington Global (Obo, Sorrento Therapeutics)
Consulting Firm, Biopharmaceutical Company
Based in MD
🤖
AI Overview
With $50K in lobbying spend across 5 quarterly filings, Stonington Global (Obo, Sorrento Therapeutics) is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2020 to 2021.
$50K
Total Spend
2
Years Active
1
Firms Hired
1
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $10K |
| 2021 | $40K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy, MED, Health Issues, Budget/Appropriations
- •FDA Approvals, Department of Health and Human Services, Clinical Trials, NIH and FDA research.
- •COVID-19 FDA medication approvals
- •COVID-19 Relief
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.